Q2 2022 Holdings
Filed 2022-08-10 | 41 holdings | $254.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $179.7M | 8,434,232 | 70.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $26.4M | 1,414,823 | 10.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $18.9M | 2,094,154 | 7.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $12.0M | 285,331 | 4.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $10.6M | 3,746,857 | 4.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.7M | 408,329 | 2.2% |
| Hillevax Inc | COM | 43157M102 | $101.5K | 9,285,682 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $71.9K | 1,095,407 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $69.4K | 3,566,912 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $62.9K | 3,595,026 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $61.5K | 3,195,403 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $49.2K | 5,827,415 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $47.9K | 870,636 | 0.0% |
| Imago Biosciences Inc | COM | 45250K107 | $39.8K | 2,971,274 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $38.9K | 1,787,405 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $26.1K | 1,787,527 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $25.4K | 2,985,757 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $20.2K | 2,082,093 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $18.3K | 899,700 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $17.1K | 3,111,551 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $15.5K | 1,572,192 | 0.0% |
| Merus N V | COM | N5749R100 | $15.3K | 673,979 | 0.0% |
| Frazier Lifesciences Acqu Co | UNIT 12/09/2025 | G3710A121 | $14.8K | 1,501,000 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $14.1K | 806,267 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $12.7K | 5,237,348 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $11.8K | 5,009,219 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.3K | 980,302 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $10.5K | 203,684 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $10.4K | 881,173 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $9.8K | 1,375,065 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $9.3K | 1,776,479 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $5.3K | 202,260 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.3K | 1,171,627 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $2.6K | 845,636 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.3K | 585,759 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.2K | 692,910 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $1.6K | 170,000 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $1.3K | 1,374,047 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $1.1K | 739,369 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $1.1K | 1,883,244 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637113 | $77 | 425,650 | 0.0% |